Home › Acute Myeloid Leukemia › Colorado › Aurora
Acute Myeloid Leukemia clinical trials in Aurora, CO
16 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RecruitingPhase 3
- Rocky Mountain Cancer Centers, Aurora
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
RecruitingPhase 1
- Children's Hospital Colorado, Aurora
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- Children's Hospital Colorado, Aurora
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RecruitingPhase 1/2
- University of Colorado, Aurora
CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML
RecruitingPhase 1
- University of Colorado Hospital, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
RecruitingPhase 1
- Anshutz Cancer Pavilion, Aurora
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Children's Hospital Colorado, Aurora
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RecruitingPhase 3
- Children's Hospital Colorado, Aurora
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- University of Colorado, Aurora
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
RecruitingPhase 1
- Children's Hospital Colorado, Aurora
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
RecruitingPhase 2
- University of Colorado, Aurora
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Children's Hospital Colorado, Aurora
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- University of Colorado, Aurora
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Rocky Mountain Cancer Centers, Aurora
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX86 studies
- New York City, NY51 studies
- Boston, MA45 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH34 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Tampa, FL29 studies
- Atlanta, GA29 studies
- Chicago, IL27 studies
- Portland, OR25 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer26 studies
- Metastatic Cancer25 studies
- Ovarian Cancer24 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Melanoma18 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.